论文部分内容阅读
近年来关于肝病患者脂蛋白代谢的报告很多。这些工作者主要研究了高密度脂蛋白的变化及卵磷脂:胆固醇酰基转移酶(LCAT)和脂蛋白脂酶的作用。健康人和动脉样硬化患者HDL-胆固醇和载脂蛋白A的测定,已成为许多人研究的课题。作者报告了肝硬变和胆汁淤积患者血清中的载脂蛋白、胆固醇和磷脂的浓度,以及用磷钨酸钠-Mg~(2+)沉淀低密度脂蛋白和极低密度脂蛋白后,HDL中的胆固醇和磷脂浓度。
In recent years, many reports on lipoprotein metabolism in patients with liver disease. These workers mainly studied the changes of high density lipoprotein and the effects of lecithin: cholesterol acyltransferase (LCAT) and lipoprotein lipase. Determination of HDL-cholesterol and apolipoprotein A in healthy individuals and in patients with arteriosclerotic disease has been the subject of much research. The authors report the serum levels of apolipoprotein, cholesterol, and phospholipid in patients with cirrhosis and cholestasis, and after HDL-Mg 2+ precipitation of LDL and very-low-density lipoprotein In the cholesterol and phospholipid concentrations.